These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis. Iwasaki A; Sakai K; Moriya K; Sasaki T; Keene DR; Akhtar R; Miyazono T; Yasumura S; Watanabe M; Morishita S; Sakai T J Biol Chem; 2016 Jan; 291(1):72-88. PubMed ID: 26553870 [TBL] [Abstract][Full Text] [Related]
5. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis. Kim KH; Kim HC; Hwang MY; Oh HK; Lee TS; Chang YC; Song HJ; Won NH; Park KK Biochem Biophys Res Commun; 2006 May; 343(4):1072-8. PubMed ID: 16579972 [TBL] [Abstract][Full Text] [Related]
7. [Fibrogenesis and fibrolysis in the liver]. Herbst H; Schuppan D; Milani S Verh Dtsch Ges Pathol; 1995; 79():15-27. PubMed ID: 8600680 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Gressner OA; Weiskirchen R; Gressner AM Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697 [TBL] [Abstract][Full Text] [Related]
9. [Fibrogenesis in the liver--fibrosis, cirrhosis]. Kovalszky I Orv Hetil; 1993 Jan; 134(2):59-64. PubMed ID: 8419883 [TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis: possible involvement of EMT. Ikegami T; Zhang Y; Matsuzaki Y Cells Tissues Organs; 2007; 185(1-3):213-21. PubMed ID: 17587827 [TBL] [Abstract][Full Text] [Related]
11. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. Parola M; Marra F; Pinzani M Mol Aspects Med; 2008; 29(1-2):58-66. PubMed ID: 18022682 [TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis: from the bench to clinical targets. Pinzani M; Rombouts K Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333 [TBL] [Abstract][Full Text] [Related]
14. Hepatic stellate cells and the reversal of fibrosis. Kisseleva T; Brenner DA J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681 [TBL] [Abstract][Full Text] [Related]
15. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. Neef M; Ledermann M; Saegesser H; Schneider V; Reichen J J Hepatol; 2006 Dec; 45(6):786-96. PubMed ID: 17050028 [TBL] [Abstract][Full Text] [Related]
16. Expression of fibronectin receptor, integrin alpha 5 beta 1 of hepatic stellate cells in rat liver fibrosis. Zhou X; Zhang Y; Zhang J; Zhu H; Zhou X; Du W; Zhang X; Chen Q Chin Med J (Engl); 2000 Mar; 113(3):272-6. PubMed ID: 11775263 [TBL] [Abstract][Full Text] [Related]
17. Liver extracellular matrix in health and disease. Bedossa P; Paradis V J Pathol; 2003 Jul; 200(4):504-15. PubMed ID: 12845618 [TBL] [Abstract][Full Text] [Related]
18. Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness. Bergijk EC; Baelde HJ; de Heer E; Killen PD; Bruijn JA Exp Nephrol; 1995; 3(6):338-47. PubMed ID: 8528678 [TBL] [Abstract][Full Text] [Related]
20. The role of integrin binding sites in fibronectin matrix assembly in vivo. Leiss M; Beckmann K; Girós A; Costell M; Fässler R Curr Opin Cell Biol; 2008 Oct; 20(5):502-7. PubMed ID: 18586094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]